# Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation

> **NCT01924065** · PHASE3 · COMPLETED · sponsor: **Suleyman Demirel University** · enrollment: 112 (actual)

## Conditions studied

- Atrial Fibrillation
- Cardioversion
- Cerebrovascular Stroke

## Interventions

- **PROCEDURE:** Cardioversion
- **DRUG:** Oral Anticoagulant

## Key facts

- **NCT ID:** NCT01924065
- **Lead sponsor:** Suleyman Demirel University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2017-08
- **Final completion:** 2024-10-29
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2024-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01924065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01924065, "Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01924065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*